PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $2,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 79,500 | $2,000 | 0.00% |
| Bellwether Investment Group, LLC | 350 | $0 | 0.00% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $0 | 0.00% |
| FINANCIAL COUNSELORS INC | 12,600 | $0 | 0.00% |
| GLENMEDE TRUST CO NA | 5,000 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 200 | $0 | 0.00% |
| Focused Wealth Management, Inc | 2,955 | $0 | 0.00% |